These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 12068889)

  • 1. [Research progresses of the synthesis and application of oligopeptide containing Arg-Gly-Asp sequence].
    Zuo BH; Fu QQ; Li TQ; Wan CX
    Space Med Med Eng (Beijing); 2002 Apr; 15(2):152-6. PubMed ID: 12068889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologically active Arg-Gly-Asp oligopeptides assume a type II beta-turn in solution.
    Johnson WC; Pagano TG; Basson CT; Madri JA; Gooley P; Armitage IM
    Biochemistry; 1993 Jan; 32(1):268-73. PubMed ID: 8418846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressory activity of the cyclodimeric peptide with RGD-sequences.
    Szewczuk Z; Buczek P; Stefanowicz P; Krajewski K; Wieczorek Z; Siemion IZ
    Acta Biochim Pol; 2001; 48(1):121-30. PubMed ID: 11440161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-adhesive and anti-thrombotic effects of integrin-inhibiting tripeptides (Arg-Gly-Asp)].
    Udvardy M
    Orv Hetil; 1995 Oct; 136(40):2155-9. PubMed ID: 7566948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RGD and other recognition sequences for integrins.
    Ruoslahti E
    Annu Rev Cell Dev Biol; 1996; 12():697-715. PubMed ID: 8970741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha v integrins as receptors for tumor targeting by circulating ligands.
    Pasqualini R; Koivunen E; Ruoslahti E
    Nat Biotechnol; 1997 Jun; 15(6):542-6. PubMed ID: 9181576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible involvement of RGD (Arg-Gly-Asp)-containing extracellular matrix proteins in rat growth plate chondrocyte differentiation in culture.
    Yasuda T; Shimizu K; Nakagawa Y; Ishikawa H; Nishihara H; Nakamura T
    J Bone Miner Res; 1996 Oct; 11(10):1430-7. PubMed ID: 8889842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Click chemistry for the synthesis of RGD-containing integrin ligands.
    Colombo M; Bianchi A
    Molecules; 2010 Jan; 15(1):178-97. PubMed ID: 20110882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arg-Gly-Asp-Ser peptide analogs suppress cartilage chondrolytic activities of integrin-binding and nonbinding fibronectin fragments.
    Homandberg GA; Hui F
    Arch Biochem Biophys; 1994 Apr; 310(1):40-8. PubMed ID: 8161219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of retinal pigment epithelial cell-induced tractional retinal detachment by disintegrins, a group of Arg-Gly-Asp-containing peptides from viper venom.
    Yang CH; Huang TF; Liu KR; Chen MS; Hung PT
    Invest Ophthalmol Vis Sci; 1996 Apr; 37(5):843-54. PubMed ID: 8603869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disintegrins: RGD-containing proteins which inhibit cell/matrix interactions (adhesion) and cell/cell interactions (aggregation) via the integrin receptors.
    Williams JA
    Pathol Biol (Paris); 1992 Oct; 40(8):813-21. PubMed ID: 1484742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relative orientation of the Arg and Asp side chains defined by a pseudodihedral angle as a key criterion for evaluating the structure-activity relationship of RGD peptides.
    Kostidis S; Stavrakoudis A; Biris N; Tsoukatos D; Sakarellos C; Tsikaris V
    J Pept Sci; 2004 Aug; 10(8):494-509. PubMed ID: 15347137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonpeptidic analogues of the Arg-Gly-Asp (RGD) sequence specifically inhibit the adhesion of human tenon's capsule fibroblasts to fibronectin.
    Hershkoviz R; Melamed S; Greenspoon N; Lider O
    Invest Ophthalmol Vis Sci; 1994 Apr; 35(5):2585-91. PubMed ID: 8163346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of angiogenesis in vitro by Arg-Gly-Asp-containing synthetic peptide.
    Nicosia RF; Bonanno E
    Am J Pathol; 1991 Apr; 138(4):829-33. PubMed ID: 1707235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and cell attachment activity of bioactive oligopeptides: RGD, RGDS, RGDV, and RGDT.
    Hirano Y; Kando Y; Hayashi T; Goto K; Nakajima A
    J Biomed Mater Res; 1991 Dec; 25(12):1523-34. PubMed ID: 1724445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for the presence of an integrin cell adhesion receptor on the oolemma of unfertilized human oocytes.
    Fusi FM; Vignali M; Busacca M; Bronson RA
    Mol Reprod Dev; 1992 Mar; 31(3):215-22. PubMed ID: 1554507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for ligand recognition by RGD (Arg-Gly-Asp)-dependent integrins.
    Takagi J
    Biochem Soc Trans; 2004 Jun; 32(Pt3):403-6. PubMed ID: 15157147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of molecular shape with GPIIb-IIIa receptor antagonist activity in RGD peptides.
    Tung JS; Jakubowski JA; Heath WF; Utterback BG; Herron DK
    Receptor; 1993; 3(4):343-56. PubMed ID: 8142908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomalized oligopeptides in cancer therapy.
    Asai T; Oku N
    Methods Enzymol; 2005; 391():163-76. PubMed ID: 15721380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective interaction of a conformationally-constrained Arg-Gly-Asp (RGD) motif with the integrin receptor alphavbeta3 expressed on human tumor cells.
    Lanza P; Felding-Habermann B; Ruggeri ZM; Zanetti M; Billetta R
    Blood Cells Mol Dis; 1997 Aug; 23(2):230-41. PubMed ID: 9268674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.